CB
Climb Bio Inc
🇺🇸XNAS.CLYMUnited StatesHealthcare
$8.82USDup +0.18 (+2.08%)OpenDelayed3:28 PM
Price$8.82+0.18 (+2.08%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US28658R1068
- CUSIP
- 28658R106
Company
- Employees
- 28
- Headquarters
- Wellesley Hills, United States
- Website
- https://climbbio.com
- CEO
- Dr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc
Market
- Shares outstanding
- 57.4M
- Market cap
- $421.31M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $421.31M
- EPS LTM
- -$0.76
- P/E LTM
- -11.66calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$57.62M-23.24%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$53.07M-33.55%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.